Cidara Therapeutics, Inc. earnings per share and revenue

A3D4A6 earnings per share for the last quarter are -2.20 EUR whereas the estimation was -3.82 EUR which accounts for 42.35% surprise. Company revenue for the same period amounts to 0.00 EUR despite the estimated figure of 389.19 k EUR. Estimated earnings per share for the next quarter are -3.38 EUR, and revenue is expected to reach 231.83 k EUR. Also watch annual changes over time to get a bigger picture of A3D4A6 earnings per share and revenue dynamics.